NCT07352696Enrolling by invitation
Combined High-Intensity Aerobic Training and Resistance Training in Psoriatic Arthritis
Effects of Combined High-Intensity Aerobic Training and Resistance Training on Cardiovascular and Metabolic Health in Psoriatic Arthritis
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
The goal of this randomised controlled trial is to evaluate the effects of a 12-week intervention comprising high-intensity interval aerobic training and strength training on cardiovascular function, metabolic health profile and inflammation in patients with Psoriatic arthritis. A secondary goal is to assess the intervention´s impact on physical fitness, pain, fatigue, and health-related quality of life, and to explore long-term maintenance of exercise following completion of the intervention. We hypothesize that 12 weeks of combined high-intensity interval aerobic training and strength training will improve cardiometabolic health, inflammation, and enhance physical fitness, fatigue, pain and quality of life in Psoriatic arthritis.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- First submitted
- 15 Dec 2025
- Start date
- 26 Jan 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Vastra Gotaland Region
- Diseases
- Psoriasis, Psoriatic arthritis
- NCT number
- NCT07352696
What you commit to
- Study type: Interventional
- Planned participants: 88
- From 26 Jan 2026 to the primary completion date, Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Ongoing or planned initiation (within 3 months) of structured weight reduction therapy, pharmacological obesity treatment, or bariatric bypass surgery
Other illness
- Cardiovascular disease
- Severe hypertension
- Diabetes type I
- Chronic obstructive pulmonary disease or other severe pulmonary diseases
- Severe functional impairment precluding participation in high-intensity aerobic exercise
Other
- Arthroplasty of large joints, lower extremities
- Inability to perform a cardiopulmonary exercise testing (CPET)
- Pregnancy
- BMI ≥35 kg/m²
- Already participating in regular exercise at high intensity (BORG ≥15) for \>1 hour/ week during the past 6 months
- Inability to understand and read Swedish
Who the study is looking for
- Psoriatic arthritis disease according to the CASPAR (Classification Criteria for Psoriatic Arthritis) criteria
- Age range 18-65 years
- Stable medication on anti- rheumatic drugs for \>3 months prior to inclusion and throughout the first 3 months of the study
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sahlgrenska University Hospital Coordinator of this site? Confirm its status | Gothenburg | Sweden | Unknown status |
| Skaraborgs sjukvård, Skövde Coordinator of this site? Confirm its status | Skövde | Sweden | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.